Thursday, 20 July 2017

Global Hemophilia Market: Industry Analysis & Outlook 2017-2021 : Expected to launch their Gene Therapy Treatment

ResearchMoz added Latest Research Report titled " Global Hemophilia Market: Industry Analysis & Outlook (2017-2021) " to it's Large Report database.

The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causes abnormal bleeding with poor clotting. It is classified into hemophilia A, hemophilia B, hemophilia C, and hemophilia with inhibitors.

Treatment for hemophilia is done via replacement therapy, prophylactic therapy, on-demand therapy, gene therapy and many others. Gene therapy is being regarded as an attractive option for treatment of hemophilia. By the year 2030, the pharmaceutical companies are expected to launch their gene therapy treatment for hemophilia, and this might affect the market dynamics at large.

Request for Sample PDF of Premium Research Report with TOC:

The growth factors of the hemophilia market include increased focus on prophylactic treatment, growing market for FVIII, increasing diagnosis rate, and increasing healthcare expenditure. Major trends of the market include development of novel hemophilia treatment, subcutaneous dosing and growing popularity of gene therapy. Further, growth prospects are hindered by high cost of therapy and consumer’s reluctance in switching to new therapy options.

The report offers an in-depth analysis of the global hemophilia market. It also covers the global as well as regional aspect of the market. The top notch players in the market exhibit a very close competition. The report profiles Pfizer Inc., Bayer Group, Shire PLC, and Novo Nordisk.

Browse more details @

Table of Content

1. Market Overview
1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis & Treatment

2. Global Market Analysis
2.1 Global Hemophilia Market by Value
2.2 Global Hemophilia Market Forecast by Value
2.3 Global Hemophilia Market by Therapeutic Class
2.3.1 Global Hemophilia Traditional Factors Market Forecast by Value
2.4 Global Hemophilia Market by Type
2.4.1 Global Hemophilia A Market Forecast by Value
2.4.2 Global Hemophilia A Market Forecast by Therapeutic Class
2.4.3 Global Hemophilia A Market by Severity
2.4.4 Global Hemophilia with Inhibitors Market Forecast by Value
2.4.5 Global Hemophilia B Market Forecast by Value
2.4.6 Global Hemophilia B Market Forecast by Therapeutic Class
2.4.7 Global Hemophilia B Market by Severity

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at:
Follow me on Blogger at:

No comments:

Post a Comment